Humana shares are trading lower after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $419 to $253.
Portfolio Pulse from Benzinga Newsdesk
Humana's stock is experiencing a decline following a downgrade by Jefferies from Buy to Hold, with a significant reduction in the price target from $419 to $253.
October 07, 2024 | 2:52 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Humana's stock is trading lower due to Jefferies' downgrade from Buy to Hold, with a price target cut from $419 to $253.
The downgrade by Jefferies, a reputable financial services company, directly impacts investor sentiment and expectations for Humana. The significant reduction in the price target suggests a less optimistic outlook, likely leading to a short-term decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100